ACT for ALS put into action with new money for early-stage research

In the USA, the National Institutes of Health (NIH) has outlined  significant new investments to support research into amyotrophic lateral sclerosis (ALS).

Noting that there is currently no cure for ALS, the government-funded agency is putting forward tens of millions of dollars to promote three projects seeking to provide more options for patients.

While there are two US Food and Drug Administration-approved drugs to treat ALS symptoms or slow progression, until recently there had been no new options for many years.